The remaining patients (11/84, 13.1%) whose lesions were stopped bleeding on DBE received medical treatment, including 54.5% ulcers, 18.2% tumors, 18.2% diverticula and 9.1% vascular abnormalities and after 128, 9 ± 110, 2 weeks 27.3% of patients had rebleeding